Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07708805 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quantitative Myocardial Perfusion Imaging Assessment by SPECT/CT

Study acronym: SUV-RESERVE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Centre Hospitalier Régional d'Orléans

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 8 more changesShow less
    • Lead sponsor: Centre Hospitalier Régional d'Orléans to Centre Hospitalier Régional d'Orléans
    • Primary endpoints: details revised at 1 of 1 entry
    • Start date changed from estimate of Aug 25, 2026 to Sep 21, 2026
    • Interventions: rest SPECT/CT (Diagnostic Test), stress SPECT/CT (Diagnostic Test) to rest SPECT/CT (Diagnostic Test), stress SPECT/CT (Diagnostic Test)
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
    • Publications: details revised at 5 of 5 entries
  2. Minor Primary endpoint(s) modified
    • Secondary endpoints: details revised at 2 of 2 entries
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Myocardial perfusion single-photon emission computed tomography (SPECT) is a well-established functional imaging technique for the assessment of coronary artery disease. Recent developments in cadmium-zinc-telluride (CZT) camera technology have enabled significant reductions in acquisition time while improving image quality. Positron emission tomography (PET) myocardial imaging remains the reference standard for the quantitative assessment of myocardial blood flow (MBF) and myocardial flow reserve (MFR); however, its use is limited by high costs and restricted availability. This exploratory study aims to evaluate the feasibility of using CZT-SPECT/CT imaging as an alternative approach by assessing the absolute quantification of myocardial tracer uptake, expressed as standardized uptake values (SUV), both at rest and during stress. The primary objective is to compare the ratio of stress-to-rest SUV obtained from SPECT with MFR values measured using PET imaging. Patients under cardiology care at the University Hospital of Orléans who are scheduled for diagnostic coronary angiography or coronary CT angiography will be invited to participate. The study procedures will be integrated into their routine clinical workflow. On Day 0, participants will undergo a PET myocardial perfusion study using Rubidium-82, including measurement of MBF and MFR, with concomitant administration of 99mTc-tetrofosmin under pharmacological stress using the same vasodilator agent. A stress CZT-SPECT/CT acquisition will then be performed immediately after the PET scan. Within seven days of the initial evaluation, participants will undergo a rest CZT-SPECT/CT acquisition. Quantitative analysis of myocardial tracer uptake will subsequently be performed to derive SUV values. The overall goal of this feasibility study is to generate preliminary data to support the design of a larger-scale clinical study. Ultimately, the study seeks to determine whether standard CZT-SPECT/CT imaging could provide a simpler, faster, and more widely accessible alternative to PET myocardial perfusion imaging for functional myocardial assessment.
Trial Details
NCT Number NCT07708805
Lead Sponsor Centre Hospitalier Régional d'Orléans
Conditions
(from sponsor)
Coronary Artery Disease, Chronic Coronary Syndrome
Related terms Coronary Artery Disease
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov